Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Vaccination of chickens with a combination vaccine against infectious laryngotracheitis (ILT) and Marek’s disease (MD)

Proposed period of release:
05/10/2012 to 31/12/2016

Name of the Institute(s) or Company(ies)
Intervet International bv, Boxmeer, The Netherlands;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
The Innovax-ILT vaccine contains the live cell-associated Herpesvirus of Turkey (HVT) strain HVT/ILT-138 in a cell-associated form. This is a vector vaccine: the HVT/ILT-138 virus strain was generated by inserting glycoprotein genes of Infectious Laryngotracheitis virus (ILTV) into the HVT strain FC-126 genome.
HVT belongs to the virus family Herpesviridae, subfamily Alphaherpesvirinae, genus "Marek's disease-like viruses" (also knows as the genus Mardivirus).

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HVTMardivirusMeleagrid herpesvirus 1-FC-126-

Final report

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known